Marketdash
Back to News

Markets Stumble as Home Depot Disappoints and Dow Drops Over 300 Points

MarketDash Editorial Team
20 days ago
U.S. stocks fell sharply Tuesday morning, with the Dow shedding over 300 points after Home Depot posted weaker-than-expected earnings and cut its outlook. Consumer discretionary stocks led the decline while biotech names saw dramatic swings.

Tuesday morning brought some serious selling pressure to Wall Street, with the Dow Jones index tumbling more than 300 points as investors digested disappointing earnings from a major retailer and reassessed economic data.

Following the opening bell, the Dow traded down 0.79% to 46,222.90, while the Nasdaq declined 0.76% to 22,531.74. The S&P 500 wasn't spared either, falling 0.37% to 6,647.90.

Sector Performance Shows Clear Divergence

The market's internal dynamics revealed an interesting split. Consumer staples shares managed to edge up 0.5% on Tuesday, suggesting investors were rotating into defensive positions. Meanwhile, consumer discretionary stocks took it on the chin, falling 1.2% as the sector bore the brunt of retail concerns.

Home Depot Misses the Mark

The headline news driving much of the pessimism came from Home Depot (HD), which reported worse-than-expected third-quarter results and lowered its full-year outlook. The home improvement giant posted adjusted earnings of $3.74 per share, missing the analyst consensus estimate of $3.85 per share. Revenue came in at $41.352 billion, which actually beat expectations of $41.137 billion, but that silver lining wasn't enough to offset concerns about the bottom line and the reduced FY25 adjusted EPS outlook.

Big Movers on the Upside

While the broader market struggled, a handful of stocks posted explosive gains. Olema Pharmaceuticals, Inc. (OLMA) absolutely skyrocketed, surging 145% to $20.91. The biotech stock jumped after Roche's lidERA Phase 3 results demonstrated superiority over aromatase inhibitors in early-breast cancer, effectively de-risking the entire SERD class development.

Can-Fite BioPharma Ltd. (CANF) wasn't far behind, jumping 66% to $0.5927 following news that a patient treated with Namodenoson has reached an overall survival of 9 years to date with complete response to treatment. Meanwhile, Creative Global Technology Holdings Limited (CGTL) climbed 28% to $1.03.

Notable Decliners

On the flip side, several stocks got hammered. Inspire Veterinary Partners, Inc. (IVP) dropped 28% to $0.3218, while MV Oil Trust (MVO) fell 24% to $2.0330.

LifeMD, Inc. (LFMD) had a particularly rough day, plummeting 27% to $3.4350 after reporting worse-than-expected third-quarter results and issuing fourth-quarter sales guidance below estimates. Making matters worse, the company also cut its FY25 sales guidance below analyst expectations.

Commodities and Global Markets

In commodity markets, oil edged up 0.3% to $60.07 per barrel, while gold slipped 0.6% to $4,048.80. Silver traded down 1.14% to $50.025, and copper fell 0.4% to $4.9935.

The selling wasn't confined to U.S. shores. European markets closed lower across the board, with the eurozone's STOXX 600 falling 1.5%. Spain's IBEX 35 Index dropped 1.8%, London's FTSE 100 declined 1.3%, Germany's DAX 40 fell 1.5%, and France's CAC 40 dipped 1.5%.

Asian markets had already set a negative tone overnight. Japan's Nikkei 225 fell 3.22%, Hong Kong's Hang Seng declined 1.72%, China's Shanghai Composite dropped 0.81%, and India's BSE Sensex slipped 0.33%.

Economic Data Roundup

On the economic front, U.S. initial jobless claims came in at 232,000 for the week ending October 18. U.S. private employers announced an average of 2,500 job cuts per week in the four weeks ending November 1, a notable improvement compared to the 11,250 average decline in the previous period. The Federal Reserve Bank of New York's general business activity index ticked up to negative 21.7 in November from negative 23.6 in October, though it remained firmly in contraction territory.

Back to News

Markets Stumble as Home Depot Disappoints and Dow Drops Over 300 Points

MarketDash Editorial Team
20 days ago
U.S. stocks fell sharply Tuesday morning, with the Dow shedding over 300 points after Home Depot posted weaker-than-expected earnings and cut its outlook. Consumer discretionary stocks led the decline while biotech names saw dramatic swings.

Tuesday morning brought some serious selling pressure to Wall Street, with the Dow Jones index tumbling more than 300 points as investors digested disappointing earnings from a major retailer and reassessed economic data.

Following the opening bell, the Dow traded down 0.79% to 46,222.90, while the Nasdaq declined 0.76% to 22,531.74. The S&P 500 wasn't spared either, falling 0.37% to 6,647.90.

Sector Performance Shows Clear Divergence

The market's internal dynamics revealed an interesting split. Consumer staples shares managed to edge up 0.5% on Tuesday, suggesting investors were rotating into defensive positions. Meanwhile, consumer discretionary stocks took it on the chin, falling 1.2% as the sector bore the brunt of retail concerns.

Home Depot Misses the Mark

The headline news driving much of the pessimism came from Home Depot (HD), which reported worse-than-expected third-quarter results and lowered its full-year outlook. The home improvement giant posted adjusted earnings of $3.74 per share, missing the analyst consensus estimate of $3.85 per share. Revenue came in at $41.352 billion, which actually beat expectations of $41.137 billion, but that silver lining wasn't enough to offset concerns about the bottom line and the reduced FY25 adjusted EPS outlook.

Big Movers on the Upside

While the broader market struggled, a handful of stocks posted explosive gains. Olema Pharmaceuticals, Inc. (OLMA) absolutely skyrocketed, surging 145% to $20.91. The biotech stock jumped after Roche's lidERA Phase 3 results demonstrated superiority over aromatase inhibitors in early-breast cancer, effectively de-risking the entire SERD class development.

Can-Fite BioPharma Ltd. (CANF) wasn't far behind, jumping 66% to $0.5927 following news that a patient treated with Namodenoson has reached an overall survival of 9 years to date with complete response to treatment. Meanwhile, Creative Global Technology Holdings Limited (CGTL) climbed 28% to $1.03.

Notable Decliners

On the flip side, several stocks got hammered. Inspire Veterinary Partners, Inc. (IVP) dropped 28% to $0.3218, while MV Oil Trust (MVO) fell 24% to $2.0330.

LifeMD, Inc. (LFMD) had a particularly rough day, plummeting 27% to $3.4350 after reporting worse-than-expected third-quarter results and issuing fourth-quarter sales guidance below estimates. Making matters worse, the company also cut its FY25 sales guidance below analyst expectations.

Commodities and Global Markets

In commodity markets, oil edged up 0.3% to $60.07 per barrel, while gold slipped 0.6% to $4,048.80. Silver traded down 1.14% to $50.025, and copper fell 0.4% to $4.9935.

The selling wasn't confined to U.S. shores. European markets closed lower across the board, with the eurozone's STOXX 600 falling 1.5%. Spain's IBEX 35 Index dropped 1.8%, London's FTSE 100 declined 1.3%, Germany's DAX 40 fell 1.5%, and France's CAC 40 dipped 1.5%.

Asian markets had already set a negative tone overnight. Japan's Nikkei 225 fell 3.22%, Hong Kong's Hang Seng declined 1.72%, China's Shanghai Composite dropped 0.81%, and India's BSE Sensex slipped 0.33%.

Economic Data Roundup

On the economic front, U.S. initial jobless claims came in at 232,000 for the week ending October 18. U.S. private employers announced an average of 2,500 job cuts per week in the four weeks ending November 1, a notable improvement compared to the 11,250 average decline in the previous period. The Federal Reserve Bank of New York's general business activity index ticked up to negative 21.7 in November from negative 23.6 in October, though it remained firmly in contraction territory.

    Markets Stumble as Home Depot Disappoints and Dow Drops Over 300 Points - MarketDash News